U.S. District Court, Eastern District of Michigan
Shook, Hardy & Bacon was at the forefront in defending a major pharmaceutical company accused of a market allocation agreement in connection with the settlement of certain patent litigation involving a generic company. We served as lead trial counsel in defending 23 class actions, involving both direct and indirect claims, individual opt-out actions, an investigation by the Federal Trade Commission, and actions by state attorneys general. After seven years, the litigation was successfully resolved. MDL 1278, In re Cardizem CD Antitrust Litigation (E.D. Mich.).